CTXR logo

Citius Pharmaceuticals (CTXR) Operating Profit

Annual Operating Profit

-$42.00 M
-$5.26 M-14.33%

September 30, 2024


Summary


Performance

CTXR Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTXRprofitabilitymetrics:

Quarterly Operating Profit

-$11.05 M
-$416.30 K-3.91%

September 30, 2024


Summary


Performance

CTXR Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTXRprofitabilitymetrics:

TTM Operating Profit

-$42.00 M
-$925.80 K-2.25%

September 30, 2024


Summary


Performance

CTXR TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTXRprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

CTXR Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-14.3%-3.9%-2.3%
3 y3 years-78.5%-3.9%-2.3%
5 y5 years-169.2%-3.9%-2.3%

CTXR Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-78.5%at low-52.4%at low-70.5%at low
5 y5-year-169.2%at low-166.9%at low-159.7%at low
alltimeall time<-9999.0%at low<-9999.0%at low<-9999.0%at low

Citius Pharmaceuticals Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-$42.00 M(+14.3%)
-$11.05 M(+3.9%)
-$42.00 M(+2.3%)
Jun 2024
-
-$10.63 M(-3.1%)
-$41.07 M(+5.0%)
Mar 2024
-
-$10.97 M(+17.4%)
-$39.11 M(+0.7%)
Dec 2023
-
-$9.34 M(-7.7%)
-$38.82 M(+5.7%)
Sep 2023
-$36.73 M(+10.3%)
-$10.12 M(+16.8%)
-$36.73 M(+7.5%)
Jun 2023
-
-$8.67 M(-18.8%)
-$34.16 M(-0.7%)
Mar 2023
-
-$10.69 M(+47.4%)
-$34.40 M(+9.9%)
Dec 2022
-
-$7.25 M(-4.0%)
-$31.31 M(-6.0%)
Sep 2022
-
-$7.55 M(-15.3%)
-$33.32 M(+7.6%)
Sep 2022
-$33.32 M(+41.6%)
-
-
Jun 2022
-
-$8.92 M(+17.5%)
-$30.97 M(+10.5%)
Mar 2022
-
-$7.59 M(-18.0%)
-$28.04 M(+13.8%)
Dec 2021
-
-$9.26 M(+78.0%)
-$24.63 M(+4.7%)
Sep 2021
-$23.53 M(+32.9%)
-$5.20 M(-13.1%)
-$23.53 M(+4.7%)
Jun 2021
-
-$5.98 M(+42.9%)
-$22.47 M(+6.1%)
Mar 2021
-
-$4.19 M(-48.7%)
-$21.17 M(-1.1%)
Dec 2020
-
-$8.16 M(+97.0%)
-$21.42 M(+20.9%)
Sep 2020
-$17.71 M(+13.5%)
-$4.14 M(-11.7%)
-$17.71 M(+2.8%)
Jun 2020
-
-$4.69 M(+5.8%)
-$17.23 M(+1.5%)
Mar 2020
-
-$4.43 M(-0.3%)
-$16.96 M(+4.9%)
Dec 2019
-
-$4.45 M(+21.6%)
-$16.17 M(+3.7%)
Sep 2019
-$15.60 M(+13.1%)
-$3.66 M(-17.4%)
-$15.60 M(-0.0%)
Jun 2019
-
-$4.43 M(+21.5%)
-$15.60 M(+18.3%)
Mar 2019
-
-$3.64 M(-6.0%)
-$13.19 M(-8.5%)
Dec 2018
-
-$3.87 M(+5.8%)
-$14.42 M(+4.6%)
Sep 2018
-$13.79 M
-$3.66 M(+81.4%)
-$13.79 M(+10.0%)
Jun 2018
-
-$2.02 M(-58.5%)
-$12.53 M(-1.9%)
Mar 2018
-
-$4.87 M(+50.1%)
-$12.77 M(+22.2%)
DateAnnualQuarterlyTTM
Dec 2017
-
-$3.24 M(+35.0%)
-$10.44 M(+4.6%)
Sep 2017
-$9.99 M(+34.1%)
-$2.40 M(+6.5%)
-$9.99 M(-9.1%)
Jun 2017
-
-$2.26 M(-11.3%)
-$10.99 M(+1.2%)
Mar 2017
-
-$2.54 M(-8.7%)
-$10.86 M(+20.8%)
Dec 2016
-
-$2.78 M(-18.2%)
-$8.99 M(+20.7%)
Sep 2016
-$7.45 M(+130.6%)
-$3.41 M(+60.2%)
-$7.45 M(+48.7%)
Jun 2016
-
-$2.13 M(+216.6%)
-$5.01 M(+37.0%)
Mar 2016
-
-$671.60 K(-46.0%)
-$3.66 M(+1.7%)
Dec 2015
-
-$1.24 M(+28.5%)
-$3.60 M(+11.3%)
Sep 2015
-$3.23 M(>+9900.0%)
-$968.40 K(+25.2%)
-$3.23 M(+42.8%)
Jun 2015
-
-$773.70 K(+27.1%)
-$2.26 M(+51.9%)
Mar 2015
-
-$608.90 K(-30.7%)
-$1.49 M(+60.1%)
Dec 2014
-
-$878.90 K(>+9900.0%)
-$930.00 K(+64.6%)
Jun 2014
-
-$1300.00(-97.4%)
-$565.00 K(-0.4%)
Mar 2014
-
-$49.80 K(-90.0%)
-$567.10 K(+7.7%)
Dec 2013
-
-$499.20 K(+3295.9%)
-$526.60 K(+1780.7%)
Sep 2013
-$28.10 K(+43.4%)
-$14.70 K(+332.4%)
-$28.00 K(+57.3%)
Jun 2013
-
-$3400.00(-63.4%)
-$17.80 K(-13.6%)
Mar 2013
-
-$9300.00(+1450.0%)
-$20.60 K(+14.4%)
Dec 2012
-
-$600.00(-86.7%)
-$18.00 K(-8.2%)
Sep 2012
-$19.60 K(-23.4%)
-$4500.00(-27.4%)
-$19.60 K(+12.0%)
Jun 2012
-
-$6200.00(-7.5%)
-$17.50 K(-4.9%)
Mar 2012
-
-$6700.00(+204.5%)
-$18.40 K(-2.1%)
Dec 2011
-
-$2200.00(-8.3%)
-$18.80 K(-26.6%)
Sep 2011
-$25.60 K
-$2400.00(-66.2%)
-$25.60 K(+10.3%)
Jun 2011
-
-$7100.00(0.0%)
-$23.20 K(+44.1%)
Mar 2011
-
-$7100.00(-21.1%)
-$16.10 K(+78.9%)
Dec 2010
-
-$9000.00
-$9000.00

FAQ

  • What is Citius Pharmaceuticals annual operating income?
  • What is the all time high annual operating profit for Citius Pharmaceuticals?
  • What is Citius Pharmaceuticals annual operating profit year-on-year change?
  • What is Citius Pharmaceuticals quarterly operating income?
  • What is the all time high quarterly operating profit for Citius Pharmaceuticals?
  • What is Citius Pharmaceuticals quarterly operating profit year-on-year change?
  • What is Citius Pharmaceuticals TTM operating income?
  • What is the all time high TTM operating profit for Citius Pharmaceuticals?
  • What is Citius Pharmaceuticals TTM operating profit year-on-year change?

What is Citius Pharmaceuticals annual operating income?

The current annual operating profit of CTXR is -$42.00 M

What is the all time high annual operating profit for Citius Pharmaceuticals?

Citius Pharmaceuticals all-time high annual operating income is -$19.60 K

What is Citius Pharmaceuticals annual operating profit year-on-year change?

Over the past year, CTXR annual operating income has changed by -$5.26 M (-14.33%)

What is Citius Pharmaceuticals quarterly operating income?

The current quarterly operating profit of CTXR is -$11.05 M

What is the all time high quarterly operating profit for Citius Pharmaceuticals?

Citius Pharmaceuticals all-time high quarterly operating income is -$600.00

What is Citius Pharmaceuticals quarterly operating profit year-on-year change?

Over the past year, CTXR quarterly operating income has changed by -$416.30 K (-3.91%)

What is Citius Pharmaceuticals TTM operating income?

The current TTM operating profit of CTXR is -$42.00 M

What is the all time high TTM operating profit for Citius Pharmaceuticals?

Citius Pharmaceuticals all-time high TTM operating income is -$9000.00

What is Citius Pharmaceuticals TTM operating profit year-on-year change?

Over the past year, CTXR TTM operating income has changed by -$925.80 K (-2.25%)